States push to ease access to ivermectin, other COVID treatments that establishment blocked
Oklahoma attorney general also says he'll leave alone doctors prescribing FDA-approved drugs for off-label COVID treatment.
Oklahoma attorney general also says he'll leave alone doctors prescribing FDA-approved drugs for off-label COVID treatment.
The doctor at the Washington County Detention Center has been promoting the use of the controversial drug for months
This story raises questions about the credibility of Rolling Stone, a local doctor and an NBC affiliate.
The Japanese trading and pharmaceutical company Kowa ran a non-clinical study with a Tokyo university
Similar bills are working their way through the legislature in Oklahoma, Missouri, Indiana, Arizona, and Alaska.
The measure will also prevent pharmacists from questioning doctors who prescribe either of the drugs.
“I think what's happening is the Board of Medical Practice has been weaponized for political purposes by people who don't agree with my positions politically,” Dr. Scott Jensen told Just the News.
Researchers will also study Fluvoxamine, an anti-depressant that has been shown to decrease inflammation.
Provision is buried in omnibus appropriations bill after FDA kept losing in court. "Potentially catastrophic for use of antibiotics," says former Public Health England director.